“Non-Burdensome” Cost-Effectiveness Trials Require Docs’ Help – McClellan

The medical community can help CMS develop real-world data about the use of new medical technologies, agency Administrator Mark McClellan told an American Medical Association conference in Washington, D.C. March 30

More from Archive

More from Medtech Insight